Forget Password?
Learn more
share this!
November 2, 2022
Researchers have shown that a blood test for early diagnosis of type 1 diabetes can stave off serious illness and hospitalization in children. 

googletag.cmd.push(function() { googletag.display(‘div-gpt-ad-1450190541376-1’); });

The innovative test is a finger prick sample that is collected in the home and mailed to the lab. 
The study, led by WEHI clinical-scientist and the Royal Melbourne Hospital (RMH) endocrinologist Associate Professor John Wentworth, looked at over 17,000 children and who were screened for type 1 using a regular .
Type 1 diabetes is an where the is activated to destroy the cells in the pancreas which produce insulin.
Without insulin, the body’s cells cannot turn glucose (sugar)into energy—meaning people with type 1 diabetes depend on insulin every day of their lives to compensate for what their body cannot naturally produce.
Wentworth, a clinician scientist at WEHI’s Population Health and Immunity division, said, “The in-home finger prick test allows us to get a result back to families sooner, which will allow us to start treatment before kids get really sick.”
“Type 1 diabetes can be very difficult to identify in children so is really important.”
“The finger prick test will allow us to start treatment before kids get really sick and will give us time to ensure families have enough time to learn how to manage type 1 diabetes, and the complexity of diet and insulin therapy.”
While the exact cause of type 1 diabetes is unknown, the condition is believed to have a strong family link and cannot be prevented.
The study primarily focused on families with a history of type 1 diabetes, due to the risk of disease being 15 times greater than the general population. However, only one in 10 newly diagnosed children have a family history of type 1 diabetes, meaning screening the entire population will be essential.
“The aim of this study is to be able to diagnose type 1 diabetes early in as many children as we can,” said Wentworth.
“Early diagnosis prevents serious illness and affords opportunities to use immunotherapy to delay progression to .”
The team of researchers are the first to use the blood spot assay to screen diabetes in Australia, and the RMH is the first in the world to prove that collected in the home provide a suitable way to control type 1 diabetes.
“We want to make type 1 diabetes screening accessible to every Australian child no matter where they live. Our recent work has proven that we can do this cheaply, accurately, and conveniently,” Wentworth said.
The study is published in Pediatric Diabetes.

More information: John M. Wentworth et al, Decreased occurrence of ketoacidosis and preservation of beta cell function in relatives screened and monitored for type 1 diabetes in Australia and New Zealand, Pediatric Diabetes (2022). DOI: 10.1111/pedi.13422

Citation: Study finds home screening test can help control type 1 diabetes (2022, November 2) retrieved 3 November 2022 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further
Feedback to editors
20 hours ago
Nov 01, 2022
Oct 31, 2022
Oct 31, 2022
Oct 28, 2022
4 minutes ago
1 hour ago
1 hour ago
10 hours ago
11 hours ago
12 hours ago
13 hours ago
Sep 06, 2021
Jan 26, 2022
Sep 08, 2021
Jul 12, 2022
Apr 30, 2019
May 27, 2022
13 hours ago
19 hours ago
13 hours ago
Nov 01, 2022
Nov 01, 2022
Nov 01, 2022
Use this form if you have come across a typo, inaccuracy or would like to send an edit request for the content on this page. For general inquiries, please use our contact form. For general feedback, use the public comments section below (please adhere to guidelines).
Please select the most appropriate category to facilitate processing of your request
Thank you for taking time to provide your feedback to the editors.
Your feedback is important to us. However, we do not guarantee individual replies due to the high volume of messages.
Your email address is used only to let the recipient know who sent the email. Neither your address nor the recipient’s address will be used for any other purpose. The information you enter will appear in your e-mail message and is not retained by Medical Xpress in any form.

Get weekly and/or daily updates delivered to your inbox. You can unsubscribe at any time and we’ll never share your details to third parties.
More information Privacy policy
Daily science news on research developments and the latest scientific innovations
The latest engineering, electronics and technology advances
The most comprehensive sci-tech news coverage on the web
This site uses cookies to assist with navigation, analyse your use of our services, collect data for ads personalisation and provide content from third parties. By using our site, you acknowledge that you have read and understand our Privacy Policy and Terms of Use.


By admin

Leave a Reply

Your email address will not be published. Required fields are marked *